University of British Columbia
Kelowna, British Columbia, V1V2L2, Canada
Location status: Recruiting
NCT Number: NCT05962164
People with Chronic Obstructive Pulmonary Disease (COPD) often develop high blood pressure and heart disease due to their sedentary lifestyle and difficulty exercising. The investigators will test if heating can mimic the health benefits of exercise by monitoring the increase in leg blood-flow using ultrasound during a 45-minute hot-water footbath. The patients will then undergo 6-weeks of hot-water footbaths to examine whether the changes to blood-flow lead to improvements in blood pressure and other indicators of heart disease risk.
Interested in participating?
Request Info40 year and older
All sexes
Interventional
Not applicable
Kelowna, British Columbia, V1V2L2, Canada
Location status: Recruiting
People with COPD are at higher risk of developing cardiovascular disease (CVD). While exercise training is a potent therapy for CVD, people with COPD have a low tolerance for exercise due to dyspnea and premature muscle fatigue. Thus, there is a need to develop more effective strategies to improve CVD risk in people with COPD. A novel way to reduce blood pressure and enhance arterial health is with passive heat therapy (PHT). An acute 45-min bout of lower limb hot-water immersion has been shown to increase leg blood flow and reduce blood pressure in healthy older adults, suggesting that PHT could have similar hypotensive and anti-atherosclerotic effects as exercise. Augmenting leg blood flow with PHT may also have functional benefits by reducing peripheral muscle fatigue and improving exercise tolerance. No study to date has looked at the acute and chronic hemodynamic and vascular responses to PHT in people with COPD, nor whether it can acutely or chronically improve exercise tolerance.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Exclusion criteria
for exercise outcomes:
The intervention will consist of 6 weeks of repeated (3x/week) 45-min lower-leg immersions.
Other names: Lower-leg Hot Water Immersion, Footbath
The sham intervention will consist of 6 weeks of repeated (3x/week) 45-min lower-leg immersions.
Time frame: 6 weeks
The change in 24-hour ambulatory systolic, diastolic and mean arterial blood pressure from baseline to post intervention.
Time frame: 6 weeks
The change in the percent dilation of the superficial femoral artery (measured using ultrasound) in response to reactive hyperemia (from a 5-min supra-systolic occlusion) from baseline to post intervention.
Time frame: 6 weeks
The change in pulse wave velocity (m/s) measured by applanation tonometry from baseline to post intervention.
Time frame: 6 weeks
The change in constant load exercise time (seconds) at 75% of peak power from baseline to post intervention.
Time frame: During procedure: 60-minutes
Superficial femoral artery blood flow (mL/min) will be measured by duplex ultrasound. Measurements will be taken every 15-min throughout immersion until 15-min following the first session of passive heat therapy or Sham treatment.
Time frame: During procedure: 60-minutes
Superficial femoral artery shear stress (1/s) patterns will be measured by duplex ultrasound. Measurements will be taken every 15-min throughout immersion until 15-min following the first session of passive heat therapy or Sham treatment.
Time frame: ~48 hours
Constant load exercise time to exhaustion (seconds) at 75% of Peak Power will be completed at baseline and 15-min after PHT or Sham Immersion. The change in post-PHT time to exhaustion from the baseline exercise trial will be compared with the change in post-sham time to exhaustion from the baseline exercise trial.
Contact information is provided by the study sponsor or research team.
Kyla Coates, MSc
CONTACT
Neil Eves, PhD
CONTACT
University of British Columbia
Other
The Acute and Chronic Benefits of Passive Heat Therapy for People With COPD
Acronym: COPD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06569940
Apnea, Asthma
Zurich, Canton of Zurich, Switzerland
View Trial DetailsNCT06652776
Bronchial Diseases, Bronchitis
Milan, Italy
View Trial DetailsNCT04492384
Body Weight, CKD
Moscow, Russia
View Trial DetailsNCT05339048
Arterial Occlusive Diseases, Arteriosclerosis
Cartagena, Departamento de Bolívar, Colombia
View Trial Details